{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:10:38Z","timestamp":1786119038599,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/qco.0b013e3282f4f237","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T10:54:58Z","timestamp":1236250498000},"page":"163-167","source":"Crossref","is-referenced-by-count":30,"title":["Bronchiectasis: new findings in the pathogenesis and treatment of this disease"],"prefix":"10.1097","volume":"21","author":[{"given":"Jonathan","family":"Ilowite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Spiegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalinee","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210205","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/thorax.57.1.15","article-title":"Bacterial colonization in patients with bronchiectasis: microbiological pattern and risk factors","volume":"57","author":"Angrill","year":"2002","journal-title":"Thorax"},{"key":"R2-10-20210205","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.rmed.2007.03.009","article-title":"Microbiologic follow-up study in adult bronchiectasis","volume":"101","author":"King","year":"2007","journal-title":"Respir Med"},{"key":"R3-10-20210205","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1183\/09031936.06.00074605","article-title":"The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis","volume":"28","author":"Davies","year":"2006","journal-title":"Eur Respir J"},{"key":"R4-10-20210205","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1183\/09031936.06.00149805","article-title":"Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics","volume":"28","author":"Fowler","year":"2006","journal-title":"Eur Respir J"},{"key":"R5-10-20210205","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/thx.2005.046631","article-title":"Nontuberculous mycobacteria in patients with bronchiectasis","volume":"60","author":"Wickremasinghe","year":"2005","journal-title":"Thorax"},{"key":"R6-10-20210205","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1183\/09031936.06.00139005","article-title":"Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis","volume":"28","author":"Kunst","year":"2006","journal-title":"Eur Respir J"},{"key":"R7-10-20210205","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1378\/chest.130.5.1503","article-title":"Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis","volume":"130","author":"Bilton","year":"2006","journal-title":"Chest"},{"key":"R8-10-20210205","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1445-5994.2007.01404.x","article-title":"Effect of long-term nebulized colistin on lung function and quality of life in patients with chronic bronchial sepsis","volume":"37","author":"Steinfort","year":"2007","journal-title":"Intern Med J"},{"key":"R9-10-20210205","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1378\/chest.122.1.213","article-title":"Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion","volume":"122","author":"Tagaya","year":"2002","journal-title":"Chest"},{"key":"R10-10-20210205","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2710.2006.00708.x","article-title":"Effects of clarithromycin on inflammatory parameters and clinical conditions in children with bronchiectasis","volume":"31","author":"Yalcon","year":"2006","journal-title":"J Clin Pharm Ther"},{"key":"R11-10-20210205","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1183\/09031936.99.13236199","article-title":"A pilot study of low-dose erythromycin in bronchiectasis","volume":"13","author":"Tsang","year":"1999","journal-title":"Eur Respir J"},{"key":"R12-10-20210205","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1378\/chest.125.2_suppl.62S","article-title":"Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa","volume":"125","author":"Wozniak","year":"2004","journal-title":"Chest"},{"key":"R13-10-20210205","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.2174\/1381612043383377","article-title":"Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitors","volume":"10","author":"Tateda","year":"2004","journal-title":"Curr Pharm Des"},{"key":"R14-10-20210205","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa043900","article-title":"A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis","volume":"354","author":"Elkins","year":"2006","journal-title":"N Engl J Med"},{"key":"R15-10-20210205","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa043891","article-title":"Mucus clearance and lung function in cystic fibrosis with hypertonic saline","volume":"354","author":"Donaldson","year":"2006","journal-title":"N Engl J Med"},{"key":"R16-10-20210205","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmonzyme Study Group","volume":"331","author":"Fuchs","year":"1994","journal-title":"N Engl J Med"},{"key":"R17-10-20210205","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1378\/chest.110.4.889","article-title":"Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmonzyme Study Group","volume":"110","author":"McCoy","year":"1996","journal-title":"Chest"},{"key":"R18-10-20210205","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","article-title":"Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group","volume":"113","author":"O'Donnell","year":"1998","journal-title":"Chest"},{"key":"R19-10-20210205","first-page":"CD002996","article-title":"Inhaled hyperosmolar agents for bronchiectasis.","volume":"2","author":"Wills","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R20-10-20210205","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1089\/jam.2006.19.100","article-title":"Hyperosmolar agents and clearance of mucus in the diseased airway","volume":"19","author":"Daviskas","year":"2006","journal-title":"J Aerosol Med"},{"key":"R21-10-20210205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1479972306074481","article-title":"A randomized evaluation of the acute efficacy, acceptability and tolerability of flutter and active cycle of breathing with and without postural drainage in noncystic fibrosis bronchiectasis","volume":"4","author":"Eaton","year":"2007","journal-title":"Chron Respir Dis"},{"key":"R22-10-20210205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1479972306075483","article-title":"Acapella\u00ae versus usual airway clearance during acute exacerbation in bronchiectasis: a randomized crossover trial","volume":"4","author":"Patterson","year":"2007","journal-title":"Chron Respir Dis"},{"key":"R23-10-20210205","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1378\/chest.06-1906","article-title":"Gastroesophageal reflux disease, acid suppression, and Mycobacterium avium complex pulmonary disease","volume":"131","author":"Thomson","year":"2007","journal-title":"Chest"},{"key":"R24-10-20210205","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1378\/chest.06-2280","article-title":"Prevalence of gastroesophageal reflux disease in patients with nontuberculous mycobacterial lung disease","volume":"131","author":"Koh","year":"2007","journal-title":"Chest"}],"container-title":["Current Opinion in Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QCO.0b013e3282f4f237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:37:32Z","timestamp":1786037852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001432-200804000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qco.0b013e3282f4f237","relation":{},"ISSN":["0951-7375"],"issn-type":[{"value":"0951-7375","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}